ReviewLeukemia2022

Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia.

Michele Baccarani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.